Organovo Invested Capital vs Enterprise Value Analysis
ONVO Stock | USD 1.10 0.05 4.35% |
Organovo Holdings financial indicator trend analysis is much more than just breaking down Organovo Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Organovo Holdings is a good investment. Please check the relationship between Organovo Holdings Invested Capital and its Enterprise Value accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.
Invested Capital vs Enterprise Value
Invested Capital vs Enterprise Value Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Organovo Holdings Invested Capital account and Enterprise Value. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Organovo Holdings' Invested Capital and Enterprise Value is -0.49. Overlapping area represents the amount of variation of Invested Capital that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Organovo Holdings, assuming nothing else is changed. The correlation between historical values of Organovo Holdings' Invested Capital and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Invested Capital of Organovo Holdings are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Invested Capital i.e., Organovo Holdings' Invested Capital and Enterprise Value go up and down completely randomly.
Correlation Coefficient | -0.49 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Organovo Holdings. There are two different methods for calculating Organovo Holdings invested capital: operating approach and financing approach. Understanding Organovo Holdings invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Enterprise Value
Enterprise Value (or EV) is usually referred to as Organovo Holdings theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Organovo Holdings debt, but would also pocket its cash. Enterprise Value is more accurate representation of Organovo Holdings value than its market capitalization because it takes into account all of Organovo Holdings existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from Organovo Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Organovo Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.As of the 19th of April 2024, Selling General Administrative is likely to grow to about 14.4 M, while Tax Provision is likely to drop 1,710.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 142K | 293K | 263.7K | 250.5K | Research Development | 3.3M | 8.9M | 8.0M | 7.6M |
Organovo Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Organovo Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Organovo Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.4M | 39.9M | 33.3M | 20.3M | 23.4M | 39.7M | |
Total Current Liabilities | 1.8M | 721K | 1.4M | 3.7M | 3.3M | 3.4M | |
Total Stockholder Equity | 26.6M | 39.2M | 30.2M | 15.3M | 17.6M | 34.6M | |
Net Debt | (27.4M) | (37.4M) | (26.5M) | (13.5M) | (12.1M) | (12.8M) | |
Retained Earnings | (279.5M) | (296.3M) | (307.7M) | (325.0M) | (292.5M) | (277.9M) | |
Accounts Payable | 720K | 281K | 415K | 331K | 380.7K | 588.6K | |
Cash | 27.4M | 37.4M | 28.7M | 15.3M | 17.6M | 16.7M | |
Cash And Short Term Investments | 27.4M | 37.4M | 28.7M | 16.0M | 18.4M | 36.2M | |
Common Stock Total Equity | 111K | 124K | 131K | 9K | 10.4K | 9.8K | |
Common Stock Shares Outstanding | 6.5M | 6.9M | 8.7M | 8.7M | 10.0M | 5.8M | |
Liabilities And Stockholders Equity | 28.4M | 39.9M | 33.3M | 20.3M | 23.4M | 39.7M | |
Other Current Assets | 851K | 1.0M | 858K | 889K | 1.0M | 882.9K | |
Other Stockholder Equity | 306.0M | 335.5M | 337.9M | 340.3M | 391.4M | 231.8M | |
Total Liab | 1.8M | 721K | 3.1M | 5.0M | 4.5M | 3.8M | |
Total Current Assets | 28.3M | 38.4M | 29.5M | 17.0M | 19.6M | 37.5M | |
Common Stock | 111K | 124K | 131K | 9K | 10.4K | 9.8K | |
Non Current Assets Total | 123K | 1.5M | 3.8M | 3.3M | 3.8M | 2.4M | |
Non Currrent Assets Other | 123K | 1.1M | 948K | 658K | 756.7K | 407.6K | |
Net Receivables | 558K | 111K | 0.0 | 152K | 136.8K | 226.8K | |
Non Current Liabilities Total | 720K | 281K | 1.7M | 1.3M | 1.5M | 1.6M | |
Property Plant And Equipment Gross | 415K | 381K | 3.9M | 3.9M | 4.5M | 2.3M | |
Other Current Liab | 1.1M | 440K | 489K | 2.8M | 2.6M | 2.9M | |
Property Plant And Equipment Net | 0.0 | 381K | 2.8M | 2.6M | 3.0M | 2.2M | |
Accumulated Other Comprehensive Income | (4.1M) | (4.6M) | (415K) | 2K | 1.8K | 1.9K | |
Intangible Assets | 123K | 109K | 94K | 13K | 11.7K | 11.1K | |
Net Tangible Assets | 26.6M | 39.1M | 30.1M | 15.3M | 13.8M | 13.1M | |
Net Invested Capital | 26.6M | 39.2M | 30.2M | 15.3M | 13.8M | 25.6M | |
Net Working Capital | 26.5M | 37.7M | 28.2M | 13.4M | 12.0M | 11.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Organovo Stock analysis
When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.027 | Quarterly Revenue Growth (0.96) | Return On Assets (0.73) | Return On Equity (1.34) |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.